Medicare Enrolled

Dorothy Lacombe, NP

Nurse Practitioner - Adult Health · Clifton Park, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
963 ROUTE 146 STE 3, Clifton Park, NY 12065
5183378993
Registered in NPPES since 2014
NPI: 1780008078 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Lacombe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Lacombe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Lacombe

Dorothy Lacombe is a nurse practitioner - adult health in Clifton Park, NY, with 12 years of NPI registration. Based on federal Medicare data, Lacombe performed 120,497 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Lacombe received a total of $35,134 from 53 pharmaceutical and/or device companies across 1058 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Lacombe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration ▲ Top 0% volume in NY $35,134 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
120,497
Medicare services
Top 0% in NY for nurse practitioner - adult health
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
68,400 $4 $15
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
27,650 $10 $40
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
22,450 $33 $80
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
557 $82 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
378 $50 $138
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
299 $47 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
244 $68 $193
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
159 $4 $15
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
95 $18 $60
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
86 $9 $30
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
72 $95 $253
Injection, methylprednisolone acetate, 40 mg 49 $5 $15
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
26 $108 $270
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
19 $37 $133
New patient office visit, complex (60-74 min) 13 $121 $332
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
42.0% high complexity
57.4% medium
0.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$35,134
Total received (2021-2024)
Avg $8,784/year across 4 years
Top 0% in NY for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,058
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,820
2023
$9,830
2022
$10,084
2021
$6,399

Payments by company (2024)

Janssen Biotech, Inc.
$5,157
ABBVIE INC.
$719
Mallinckrodt Hospital Products Inc.
$474
PFIZER INC.
$462
UCB, Inc.
$365
Amgen Inc.
$292
GlaxoSmithKline, LLC.
$169
Lilly USA, LLC
$166
ANI Pharmaceuticals, Inc.
$154
AstraZeneca Pharmaceuticals LP
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Genentech USA, Inc.
$88
Actelion Pharmaceuticals US, Inc.
$63
SCILEX PHARMACEUTICALS INC.
$59
Organon Llc
$58
Fresenius Kabi USA, LLC
$55
GENZYME CORPORATION
$46
TG Therapeutics, Inc.
$41
DePuy Synthes Sales Inc.
$35
Novo Nordisk Inc
$35
Aurinia Pharma U.S., Inc.
$34
SOBI, INC
$31
Sandoz Inc.
$19
IBSA Pharma Inc.
$18
Teva Pharmaceuticals USA, Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Novartis Pharmaceuticals Corporation
$15
Alnylam Pharmaceuticals Inc.
$14
Dermavant Sciences, Inc.
$13
Octapharma USA, Inc.
$13
Top 3 companies account for 72.0% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$10,323
Janssen Scientific Affairs, LLC
$10,169
UCB, Inc.
$2,182
ABBVIE INC.
$2,070
Mallinckrodt Hospital Products Inc.
$1,576
PFIZER INC.
$1,341
GlaxoSmithKline, LLC.
$758
Horizon Therapeutics plc
$719
Lilly USA, LLC
$634
AstraZeneca Pharmaceuticals LP
$486
AbbVie Inc.
$454
Novartis Pharmaceuticals Corporation
$334
Aurinia Pharma U.S., Inc.
$317
Fresenius Kabi USA, LLC
$308
Amgen Inc.
$305
ANI Pharmaceuticals, Inc.
$295
GENZYME CORPORATION
$275
E.R. Squibb & Sons, L.L.C.
$250
Actelion Pharmaceuticals US, Inc.
$210
Boehringer Ingelheim Pharmaceuticals, Inc.
$201
Boston Scientific Corporation
$199
Genentech USA, Inc.
$195
Organon LLC
$168
Lundbeck LLC
$136
Novo Nordisk Inc
$131
Kowa Pharmaceuticals America, Inc.
$111
TG THERAPEUTICS, INC.
$95
Takeda Pharmaceuticals U.S.A., Inc.
$80
ARBOR PHARMACEUTICALS, INC.
$74
Antares Pharma, Inc.
$60
SCILEX PHARMACEUTICALS INC.
$59
Organon Llc
$58
SANOFI-AVENTIS U.S. LLC
$55
DePuy Synthes Sales Inc.
$51
Biohaven Pharmaceuticals, Inc.
$48
TG Therapeutics, Inc.
$41
Teva Pharmaceuticals USA, Inc.
$37
Arcutis Biotherapeutics, Inc.
$35
Biogen, Inc.
$33
CSL Behring
$33
SOBI, INC
$31
Bioventus LLC
$27
Sandoz Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
IBSA Pharma Inc.
$18
Biohaven Pharmaceutical Holding Company Ltd.
$17
Nevro Corp.
$17
Hikma Pharmaceuticals USA
$16
Fidia Pharma USA Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
Dermavant Sciences, Inc.
$13
Octapharma USA, Inc.
$13
Currax Pharmaceuticals LLC
$12
Top 3 companies account for 64.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · BRIUMVI · Bimzelx · COMIRNATY · CONTRAVE · COSENTYX · CUVITRU · CYLTEZO · Cimzia · Durolane · EVUSHELD · GIVLAARI · HADLIMA · HUMIRA · HYMOVIS · HYQVIA · HYRIMOZ · Hizentra · Horizant · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · Livalo · MONOVISC · Mitigare · NURTEC ODT · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · OTREXUP · Ocrevus · Ocrevus Zunovo · Omnia · PANZYGA · PENNSAID · PURIFIED CORTROPHIN GEL · QULIPTA · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SEGLENTIS · SIMPONI ARIA · SKYRIZI · STRENSIQ · Saxenda · Seglentis · TALTZ · TAVNEOS · TREMFYA · TYSABRI · Tirosint · Truxima · UBRELVY · UPLIZNA · UPTRAVI · VTAMA · VYEPTI · Wegovy · XELJANZ · XYOSTED · ZEPBOUND · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - adult health in Clifton Park?
Compare adult-health nurse practitioners in the Clifton Park area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners in nearby ZIP areas
145
County median income
$99,653
Nearest hospital to ZIP centroid (approximate)
ELLIS HOSPITAL
7.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Lacombe is a mixed practice specialist, with above-average Medicare volume (top 0% in NY).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Lacombe experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Lacombe performed 68,400 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Lacombe receive payments from pharmaceutical companies?
Yes. Lacombe received a total of $35,134 from 53 companies across 1,058 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Lacombe's costs compare to other adult-health nurse practitioners in Clifton Park?
Lacombe's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Lacombe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →